|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Plasma-Lyte 148: A clinical review显示文摘AIM To outline the physiochemical properties and specific clinical uses of Plasma-Lyte 148 as choice of solution for fluid intervention in critical illness, surgery and perioperative medicine.METHODS We performed an electronic literature search from Medline and Pub Med(via Ovid), anesthesia and pharmacology textbooks, and online sources including studies that compared Plasma-Lyte 148 to other crystalloid solutions. The following keywords were used: 'surgery', 'anaesthesia', 'anesthesia', 'anesthesiology', 'anaesthesiology', 'fluids', 'fluid therapy', 'crystalloid', 'saline', 'plasma-Lyte', 'plasmalyte', 'hartmann's', 'ringers' 'acetate', 'gluconate', 'malate', 'lactate'. All relevant articles were accessed in full. We summarized the data and reported the data in tables and text. RESULTS We retrieved 104 articles relevant to the choice of Plasma-Lyte 148 for fluid intervention in critical illness, surgery and perioperative medicine. We analyzed the data and reported the results in tables and text.CONCLUSION Plasma-Lyte 148 is an isotonic, buffered intravenous crystalloid solution with a physiochemical composition that closely reflects human plasma. Emerging data supports the use of buffered crystalloid solutions in preference to saline in improving physicochemical outcomes. Further large randomized controlled trials assessing the comparative effectiveness of PlasmaLyte 148 and other crystalloid solutions in measuring clinically important outcomes such as morbidity and mortality are needed. | Laurence Weinberg Neil Collins Kiara Van Mourik Chong Tan Rinaldo Bellomo | 2016 | World Journal of Critical Care Medicine2016，5，4： | 5 |
| 2 | Arterial complications, venous thromboembolism and deep venous thrombosis prophylaxis after anterior cruciate ligament reconstruction: A systematic review显示文摘AIM To summarize the current knowledge on vascular complications and deep venous thrombosis(DVT) prophylaxis after anterior cruciate ligament(ACL) reconstruction.METHODS A systematic review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses statement. MEDLINE, EMBASE, Cochrane,Web of Science, CINAHL, PubMed publisher, and Google scholar medical literature databases were searched up to November 10, 2015. Any arthroscopic surgical method of primary or revision intra-articular ACL reconstruction of all graft types in humans was included. A risk of bias assessment was determined.RESULTS Fourty-seven studies were included in the review.Pseudaneurysms were the most frequently reported arterial complication after ACL reconstruction, irrespective of graft type or method of graft fixation with an incidence of 0.3%. The time to diagnosis of arterial complications after ACL reconstruction varied from days to mostly weeks but even years. After ACL reconstruction without thromboprophylaxis, the incidence of DVT was 9.7%, of which 2.1% was symptomatic. The incidence of pulmonary embolism was 0.1%. Tourniquet time > 2 h was related to venous thromboembolism.Thromboprophylaxis is indicated in patients with risk factors for venous thromboembolism.CONCLUSION After ACL reconstruction, the incidence of arterial complications,symptomatic DVT and pulmonary embolism was 0.3%, 2.1% and 0.1% respectively. Arterial complications may occur with all types of arthroscopic ACL reconstruction, methods of graft fixation as well as any type of graft. Patients considered to be at moderate or high risk of venous thromboembolism should routinely receive thromboprophylaxis after ACL reconstruction. | Rob Paulus Augustinus Janssen Max Reijman Daan Martijn Janssen Jan Bernardus Antonius van Mourik | 2016 | World Journal of Orthopedics2016，7，9： | 4 |
| 3 | Value of a comprehensive geriatric assessment for predicting one-year outcomes in patients undergoing transcatheter aortic valve implantation: results from the CGA-TAVI multicentre registry显示文摘Background In a three-month report from the CGA-TAVI registry, we found the Multidimensional Prognostic Index (MPI) and Short Physical Performance Battery (SPPB) to be of value for predicting short-term outcomes in elderly patients undergoing transcatheter aortic valve implantation (TAVI). In the present analysis, we examined the association of these tools with outcomes up to one year post-TAVI. Methods CGA-TAVI is an international, observational registry of geriatric patients undergoing TAVI. Patients were assessed using the MPI and SPPB. Efficacy of baseline values and any postoperative change for predicting outcome were established using logistic regression. Kaplan- Meier analysis was carried out for each comprehensive geriatric assessment tool, with survival stratified by risk category. Results One year after TAVI, 14.1% of patients deceased, while 17.4% met the combined endpoint of death and/or non-fatal stroke, and 37.7% the combined endpoint of death and/or hospitalisation and/or non-fatal stroke. A high-risk MPI score was associated with an increased risk of all-cause mortality (aOR = 36.13, 95% CI: 2.77–470.78, P = 0.006) and death and/or non-fatal stroke (aOR = 10.10, 95% CI: 1.48–68.75, P = 0.018). No significant associations were found between a high-risk SPPB score and mortality or two main combined endpoints. In contrast to a worsening SPPB, an aggravating MPI score at three months post-TAVI was associated with an increased risk of death and/or non-fatal stoke at one year (aOR = 95.16, 95% CI: 3.41–2657.01). Conclusions The MPI showed value for predicting the likelihood of death and a combination of death and/or non-fatal stroke by one year after TAVI in elderly patients. | Martijn S.van Mourik Nathalie van der Velde Giulio Mannarino Marie-Pierre Thibodeau Jean-Bernard Masson Gennaro Santoro Jan Baan Sofie Jansen Jana Kurucova Martin Thoenes Cornelia Deutsch ANDreas W.Schoenenberger ANDrea Ungar Peter Bramlage M Marije Vis | 2019 | Journal of Geriatric Cardiology2019，16，6： | 3 |
| 4 | Signatures of Majorana fermions in hybrid superconductor-semiconductor nanowire devices显示文摘 | Mourik V Zuo K Frolov S M | | 0，，6084： | 1 |
| 5 | Efficacy of neoral in the immediate positive period in child poet-fiver transplantation显示文摘 | Van Mourik ID Mdendinez HV Thrnoson M | 1998 | Liver Transpl Surg1998，4，6： | 1 |
| 6 | Effects of setuperrors and shape changes on breast radiotherapy显示文摘 | van Mourik A van Kranen S den Hollander S | 2011 | Int J RadiatOncol Biol Phys2011，79，5： | 1 |
| 7 | Ultrafast tryptophan-to-heme electron transfer in myoglobins revealed by UV 2D spectroscopy显示文摘 | Consani C Aubock G van Mourik F | 2013 | Science2013，339，6127： | 1 |
| 8 | Efficacy of neoral in the immediate postoperative period in children post-liver transplantion显示文摘 | Van Mourik ID Melendez HV Thomson M | 1998 | Liver Transpl Sur1998，4，6： | 1 |
| 9 | P-316 Improved stage-specific survival of NSCLC in North-Holland/Flevoland,the Netherlands — Effect of intensified treatment or stage migration?显示文摘 | O. Visser J. Belderbos H. Kwa J. Van Mourik | 2005 | Lung Cancer2005，，： | 1 |
| 10 | Efficient dredging: the next generation显示文摘 | BRAADBAART J MOURIK M W | 2004 | Ports and Dredging2004，162，： | 1 |
| 11 | Stem cell fac- tor consistently improves thymopoiesis after experimental transplanta- tion of murine or human hematopoietic stem cells in immunodeficient mice 显示文摘 | WILS E J ROMBOUTS E J Van MOURIK I | 2011 | J Immunol2011，187，6： | 1 |
| 12 | Modulating societal acceptance in new energy projects: Towards a toolkit methodology for project managers显示文摘 | Raven R P J M Mourik R M Feenstra C F J | 2009 | Energy2009，34，： | 1 |
| 13 | Cognition in global aphasia:indicators for therapy显示文摘 | Van Mourik M Verschaene M Boon P | 1992 | Aphasiology1992，6，5： | 1 |
| 14 | Simulation of capillary flow with a dynamic contact angle 显示文摘 | VAN MOURIK S VELDMAN A E P DREYER M E | 2005 | Microgravity- Seience and Technology2005，17，3： | 1 |
| 15 | Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment 显示文摘 | van Mourik MS Macklon NS Heijnen CJ | 2009 | J Leukoe Biol2009，85，1： | 1 |
| 16 | Settup errors and shape changes on breast radiotherapy 显示文摘 | Mourik A V Kranen S V Hollander S D | 2011 | Int J Radioation Oncology Biol Phys2011，79，5： | 1 |
| 17 | Differential activa-tion of human and mouse Toll-like receptor 4 by the adjuvant can-didate LpxL1 of Neisseria meningitidis显示文摘 | Steeghs L Keestra AM van Mourik A | 2008 | Infect Immun2008，76，8： | 1 |
| 18 | Embryonic implantation:cytokines,adhesion mole-cules,and immune cells in establishing an implanta-tion environment显示文摘 | MOURIK M S MACKLON N S HEIJNEN C J | 2009 | J Leukoc Biol2009，85，1： | 1 |
| 19 | 查看详情显示文摘 | Mourik T V Wilson A K Dunning T H | | 0，，： | 1 |
| 20 | Modulating societal acceptance in new energy projects: Towards a toolkit methodology for project managers 显示文摘 | Raven R P J M Mourik R M Feenstra C F J | 2009 | Energy2009，34，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员